Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders

American Journal of Pathology

Volumn 169, Issue 6, 2006, Pages 2085-2093

  Szalay, Gudrun ^a   Sauter, Martina ^a   Hald, Joachim ^a   Weinzierl, Andreas ^a   Kandolf, Reinhard ^a   Klingel, Karin ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NOS2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; CYTOKINE RELEASE; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; MOUSE; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS REPLICATION; ANIMAL; ANTIBODY PRODUCTION; BIOSYNTHESIS; C57BL MOUSE; COXSACKIE VIRUS INFECTION; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SECRETION;

ANIMALS; ANTIBODY FORMATION; COXSACKIEVIRUS INFECTIONS; INTERFERON TYPE II; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDITIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 38749120919     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.060350     Document Type: Article

References (39)

1. Martino TA, Liu P, Sole MJ: Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 1994, 74:182-188
2. Klingel K, Sauter M, Bock CT, Szalay G, Schnorr JJ, Kandolf R: Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol (Berl) 2004, 193:101-107
3. Kandolf R, Selinka HC, Klingel K: Pathogenesis of coxsackievirus B infections. Molecular Biology of Picornaviruses. Edited by BL Semler, E Wimmer. Washington, DC, American Society of Microbiology, 2002, pp 405-413
4. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R: Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 1992, 89:314-318
5. Chow LH, Beisel KW, McManus BM: Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest 1992, 66:24-31
6. Capobianchi MR, Matteucci D, Giovannetti A, Soldaini E, Bendinelli M, Stanton JG, Dianzani F: Role of interferon in lethality and lymphoid atrophy induced by coxsackievirus B3 infection in mice. Viral Immunol 1991, 4:103-110
7. Mena I, Perry CM, Harkins S, Rodriguez F, Gebhard J, Whitton JL: The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol 1999, 155:1205-1215
8. Henke A, Huber S, Stelzner A, Whitton JL: The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 1995, 69:6720-6728
9. Opavsky MA, Penninger J, Aitken K, Wen WH, Dawood F, Mak T, Liu P: Susceptibility to myocarditis is dependent on the response of alpha/beta T lymphocytes to coxsackieviral infection. Circ Res 1999, 85:551-558
10. Godney EK, Arizpe HM, Gauntt CJ: Characterization of the antibody response in vaccinated mice protected against coxsackievirus B3-induced myocarditis. Viral Immunol 1987, 1:305-314
11. Klingel K, Schnorr JJ, Sauter M, Szalay G, Kandolf R: Beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis. Am J Pathol 2003, 162:1709-1720
12. Zaragoza C, Ocampo C, Saura M, Leppo M, Wei XQ, Quick R, Moncada S, Liew FY, Lowenstein CJ: The role of inducible nitric oxide synthase in the host response to coxsackievirus myocarditis. Proc Natl Acad Sci USA 1998, 95:2469-2474
13. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, 271:C1424-C1437
14. Moore KW, de Waal MR, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765
15. Seko Y, Takahashi N, Yagita H, Okumura K, Yazaki Y: Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus B3. J Pathol 1997, 183:105-108
16. Hofmann P, Schmidtke M, Stelzner A, Gemsa D: Suppression of proinflammatory cytokines and induction of IL-10 in human monocytes after coxsackievirus B3 infection. J Med Virol 2001, 64:487-498
17. Kandolf R, Hofschneider PH: Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci USA 1985, 82:4818-4822
18. Eriksson U, Kurrer MO, Bingisser R, Eugster HP, Saremaslani P, Follath F, Marsch S, Widmer U: Lethal autoimmune myocarditis in interferon-γ receptor-deficient mice. Circulation 2001, 103:18-21
19. Schaffer MR, Efron PA, Thornton FJ, Klingel K, Gross SS, Barbul A: Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol 1997, 158:2375-2381
20. Henke A, Zell R, Ehrlich G, Stelzner A: Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis. J Virol 2001, 75:8187-8194
21. Horwitz MS, La CA, Fine C, Rodriguez E, Ilic A, Sarvetnick N: Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med 2000, 6:693-697
22. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Gatewood SJ, Rose NR: IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol 2005, 174:261-269
23. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Gatewood SJ, Njoku DB, Rose NR: Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol 2004, 165:1883-1894
24. Costa-Pereira AP, Williams TM, Strobl B, Watling D, Briscoe J, Kerr IM: The antiviral response to gamma interferon. J Virol 2002, 76:9060-9068
25. Zaragoza C, Ocampo CJ, Saura M, McMillan A, Lowenstein CJ: Nitric oxide inhibition of coxsackievirus replication in vitro. J Clin Invest 1997, 100:1760-1767
26. Bogdan C: Nitric oxide and the immune response. Nat Immunol 2001, 2:907-916
27. Robinson NM, Zhang HY, Bevan AL, De Belder AJ, Moncada S, Martin JF, Archard LC: Induction of myocardial nitric oxide synthase by Coxsackie B3 virus in mice. Eur J Clin Invest 1999, 29:700-707
28. Gluck B, Schmidtke M, Merkle I, Stelzner A, Gemsa D: Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice. J Mol Cell Cardiol 2001, 33:1615-1626
29. Badorff C, Fichtlscherer B, Rhoads RE, Zeiher AM, Muelsch A, Dimmeler S, Knowlton KU: Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: a protective mechanism against enteroviral cardiomyopathy. Circulation 2000, 102:2276-2281
30. Shimojo T, Hiroe M, Ishiyama S, Ito H, Nishikawa T, Marumo F: Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. Exp Cell Res 1999, 247:38-47
31. Nishio R, Matsumori A, Shioi T, Ishida H, Sasayama S: Treatment of experimental viral myocarditis with interleukin-10. Circulation 1999, 100:1102-1108
32. Nakano A, Matsumori A, Kawamoto S, Tahara H, Yamato E, Sasayama S, Miyazaki JI: Cytokine gene therapy for myocarditis by in vivo electroporation. Hum Gene Ther 2001, 12:1289-1297
33. Watanabe K, Nakazawa M, Fuse K, Hanawa H, Kodama M, Aizawa Y, Ohnuki T, Gejyo F, Maruyama H, Miyazaki J: Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation. Circulation 2001, 104:1098-1100
34. Kaya Z, Dohmen KM, Wang Y, Schlichting J, Afanasyeva M, Leuschner F, Rose NR: Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J Immunol 2002, 168:1552-1556
35. Jarasch N, Martin U, Kamphausen E, Zell R, Wutzler P, Henke A: Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3. Viral Immunol 2005, 18:355-364
36. Palaniyandi SS, Watanabe K, Ma M, Tachikawa H, Kodama M, Aizawa Y: Inhibition of mast cells by interleukin-10 gene transfer contributes to protection against acute myocarditis in rats. Eur J Immunol 2004, 34:3508-3515
37. Knowlton KU, Yajima T: Interleukin-10: biomarker or pathologic cytokine in fulminant myocarditis? J Am Coll Cardiol 2004, 44:1298-1300
38. Nishii M, Inomata T, Takehana H, Takeuchi I, Nakano H, Koitabashi T, Nakahata J, Aoyama N, Izumi T: Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol 2004, 44:1292-1297
39. de Belder AJ, Radomski MW, Why HJ, Richardson PJ, Martin JF: Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br Heart J 1995, 4:426-430